# Apremilast and Moderate to Severe Chronic Hand Dermatitis

> **NCT03741933** · PHASE4 · WITHDRAWN · sponsor: **George Washington University**

## Conditions studied

- Chronic Hand Dermatitis

## Interventions

- **DRUG:** Apremilast 30mg

## Key facts

- **NCT ID:** NCT03741933
- **Lead sponsor:** George Washington University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-02-28
- **Primary completion:** 2019-08-01
- **Final completion:** 2019-08-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The principal investigator left George Washington University and closed the study at their departure.
- **Last updated:** 2023-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03741933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03741933, "Apremilast and Moderate to Severe Chronic Hand Dermatitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03741933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*